|
WHAT'S THIS?
|
Home
About us
Email sign up
Basics
Commentary
Viewpoints
Press releases
Resources
Directory
|
|
|
|
|
|
This is a freely accessible online resource for everyone involved in publication planning. Help us build the site into a valuable resource for, amongst others, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and publishers.
Please send your ideas, contributions and comments about the articles to the Editor of The Publication Plan, Mary Greenacre.
If you have any other comments about the service, the web site, or questions about advertising and sponsorship, please contact the Publisher, Peter Llewellyn.
|
|
|
Related Sites
|
|
PRESS RELEASES << GPP2: New Good Publication Practice
|
GPP2: New Good Publication Practice
Published 1 October 2008
Submitted by Chris Graf, ISMPP, Co-Chair, Standards & Best Practices Committee; Associate Editorial Director, Wiley-Blackwell and Elizabeth (Betts) Field, ISMPP Cofounder; President, Field Advantage Medical Communications.
GPP: A Decade Later
Good Publication Practice (GPP)1,2 is the first port-of-call for publication professionals looking for guidance about publishing clinical and preclinical information, especially when this information has been gathered, analysed, or written with pharmaceutical, biotech or medical device company support.
But consider this: the first ideas for GPP were formed during a retreat of the Council of Biology Editors (now Council of Science Editors or CSE) a decade ago.2,3 With all that has happened since, it’s safe to say the time is right for GPP2: a new, revised version of Good Publication Practice.
“When we published GPP we always intended to revise it and keep it up to date but we never found the time or funding for this. While I'm still proud of what GPP has achieved and believe the underlying principles are still relevant today, things have definitely moved on in the 10 years since it was first discussed, and I am delighted that ISMPP is taking a lead in developing GPP2” says Elizabeth Wager, first author of the original publication.
A first draft of GPP2 is currently being developed by the GPP2 steering committee, coordinated by Chris Graf, and supported by the International Society for Medical Publication Professionals4 (ISMPP).
GPP2 will follow the mission laid out by the original GPP authors and “encourage responsible and ethical publication of the results of clinical trials sponsored by pharmaceutical companies”.2 Like its predecessor, GPP2 will deliver ‘best practice’ ethical guidance about peer-reviewed publications and presentations at scientific meetings, as well as recommendations for ‘non-peer-reviewed scientific communications’2. New sections will provide guidance on recent developments in medical research and reporting, such as clinical trial registration and results disclosure.
“With all that’s happened over the years since the publication of GPP, this update could not be more timely. ISMPP is proud to spearhead this initiative, which will serve to strengthen the credibility of industry-sponsored clinical publications. One of the goals of ISMPP is to be involved in initiatives that educate and benefit our members, and this one is certainly high on our list”, says Gene Snyder, ISMPP President.
You Can Help
The GPP2 steering committee will open consultation on the first draft of its new guidelines, which are expected to be ready for review before the end of 2008.
To contribute to this consultation you must have >10 years experience in three or more of the following areas:
Setting publication policies in commercial organizations
Design, conduct, and reporting of clinical trials
Legal and regulatory requirements on conducting, registering, and reporting clinical trials publications as part of a clinical development program
Common editorial and journal practices, including peer review
Scientific or medical writing and editing
Contribute to GPP2. Contact Chris Graf by email: chris.graf@wiley.com or phone: +44 1865 476 393 no later than 14 November, 2008.
Footnotes
1. http://www.gpp-guidelines.org/ accessed 12 September 2008.
2. Wager E, Field E, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin. 2003;19:149–154.
3. Council of Biology Editors is now Council of Science editors, http://www.councilscienceeditors.org/. Accessed 12 September 2008.
4. http://www.ismpp.org/. Accessed 12 September 2008.
|
Feedback: Do you have any comments about this article? Contact the Editor, Mary Greenacre.
|
|
|
